Latest Breaking News On - Florent malard - Page 1 : comparemela.com

MaaT Pharma to Host Virtual KOL Event on MaaT013 and MaaT033 Following ASH 2023 Presentations

MaaT Pharma to Host Virtual KOL Event on MaaT013 and MaaT033 Following ASH 2023 Presentations
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited statesStefan klotterFlorent malardMohamad mohtySorbonne universitySenior pr corporate communicationsCellular therapy department at saint antoine hospitalAmerican society of hematologyProfessor of hematology at sorbonne universityTrophic communicationsEarly access programAmerican societyAnnual meetingMicrobiome ecosystemKey opinion leader

MaaT Pharma to Host Virtual KOL Event on MaaT013 and MaaT033 Following ASH 2023 Presentations

MaaT Pharma to Host Virtual KOL Event on MaaT013 and MaaT033 Following ASH 2023 Presentations
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesFlorent malardMohamad mohtyCellular therapy department at saint antoine hospitalSorbonne universitySenior pr corporate communicationsTrophic communicationsProfessor of hematology at sorbonne universityEarly access programAmerican society of hematologyAmerican societyAnnual meetingMicrobiome ecosystemKey opinion leaderGraft versus host disease

MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT

MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Florent malardEuropean medicines agencyTrophic communicationsSenior pr corporate communicationsEuropean society for bloodSorbonne universityMicrobiome ecosystemSaint antoine hospitalOverall survivalOrphan drug designationEuropean societyMarrow transplantationMaat pharmaMicrobiome ecosystem therapiesEuronext parisInvestor relations

MaaT Pharma Announces Two Poster Presentations for MaaT013 and MaaT033 at the Upcoming ASH Conference

LYON, France, November 02, 2023 Regulatory News: MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, announced today that extended results from its Early Access Program of MaaT013 in 111 patients (additional 30 patients included in the Program compared to last year) with aGvHD and the design of its Phase 2b study evaluating MaaT033

San diegoUnited statesSan diego convention centerFlorent malardAmerican society of hematologyTrophic communicationsEarly access program of maaSenior pr corporate communicationsCorporate communicationsSociety for immunotherapy of cancerSorbonne universityEarly access programCellulaire congressGraft vs host diseaseMaat pharmaRegulatory news

MaaT Pharma Announces Two Poster Presentations for MaaT013 and MaaT033 at the Upcoming ASH Conference

MaaT Pharma Announces Two Poster Presentations for MaaT013 and MaaT033 at the Upcoming ASH Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSan diego convention centerFlorent malardEarly access program of maaSociety for immunotherapy of cancerSenior pr corporate communicationsCorporate communicationsCellulaire congressTrophic communicationsSorbonne universityAmerican society of hematologyEarly access programGraft vs host diseaseMaat pharmaMicrobiome ecosystem